Long-term pituitary function and functional and patient-reported outcomes in severe acquired brain injury

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Long-term pituitary function and functional and patient-reported outcomes in severe acquired brain injury. / Marina, Djordje; Feldt-Rasmussen, Ulla; Klose, Marianne.

I: European Journal of Endocrinology, Bind 190, Nr. 5, 2024, s. 382-390.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Marina, D, Feldt-Rasmussen, U & Klose, M 2024, 'Long-term pituitary function and functional and patient-reported outcomes in severe acquired brain injury', European Journal of Endocrinology, bind 190, nr. 5, s. 382-390. https://doi.org/10.1093/ejendo/lvae047

APA

Marina, D., Feldt-Rasmussen, U., & Klose, M. (2024). Long-term pituitary function and functional and patient-reported outcomes in severe acquired brain injury. European Journal of Endocrinology, 190(5), 382-390. https://doi.org/10.1093/ejendo/lvae047

Vancouver

Marina D, Feldt-Rasmussen U, Klose M. Long-term pituitary function and functional and patient-reported outcomes in severe acquired brain injury. European Journal of Endocrinology. 2024;190(5):382-390. https://doi.org/10.1093/ejendo/lvae047

Author

Marina, Djordje ; Feldt-Rasmussen, Ulla ; Klose, Marianne. / Long-term pituitary function and functional and patient-reported outcomes in severe acquired brain injury. I: European Journal of Endocrinology. 2024 ; Bind 190, Nr. 5. s. 382-390.

Bibtex

@article{8d9f9eaad76c4ab5be47fd4e36e419ba,
title = "Long-term pituitary function and functional and patient-reported outcomes in severe acquired brain injury",
abstract = "Objective: Assessment of posttraumatic hypothalamic–pituitary dysfunctions is expected to be the most relevant assessment to offer patients with severe intracranial affection. In this study, we aim to investigate the prevalence of hypopituitarism in patients with severe acquired traumatic brain injury (TBI) compared with nontraumatic brain injury (NTBI) and to relate pituitary insufficiency to functional and patient-reported outcomes. Design: This is a prospective study. Methods: We included patients admitted for inpatient neurorehabilitation after severe TBI (N = 42) and NTBI (N = 18). The patients underwent a pituitary function assessment at a mean of 2.4 years after the injury. Functional outcome was assessed by using Functional Independence Measure and Glasgow Outcome Scale-Extended (both 1 year after discharge from neurorehabilitation) and patient-reported outcome was assessed by using Multiple Fatigue Inventory-20 and EQ-5D-3L. Results: Hypopituitarism was reported in 10/42 (24%) patients with TBI and 7/18 (39%) patients with NTBI (P = .23). Insufficiencies affected 1 axis in 14/17 (82%) patients (13 hypogonadotropic hypogonadism and 1 growth hormone [GH] deficiency) and 2 axes in 3/17 (18%) patients (1 hypogonadotropic hypogonadism and GH deficiency, and 2 hypogonadotropic hypogonadism and arginin vasopressin deficiency). None had central hypoadrenalism or central hypothyroidism. In patients with both TBI and NTBI, pituitary status was unrelated to functioning and ability scores at 1 year and to patient-reported outcome scores at a mean of 2.4 years after the injury. Conclusion: Patients with severe acquired brain injury may develop long-term hypothalamus–pituitary insufficiency, with an equal occurrence in patients with TBI and NTBI. In both types of patients, mainly isolated deficiencies, most commonly affecting the gonadal axis, were seen. Insufficiencies were unrelated to functional outcomes and patient-reported outcomes, probably reflecting the complexity and heterogeneous manifestations in both patient groups.",
keywords = "acquired brain injury, functional outcome, neurorehabilitation, patient-reported outcome, pituitary function, traumatic brain injury",
author = "Djordje Marina and Ulla Feldt-Rasmussen and Marianne Klose",
note = "Publisher Copyright: {\textcopyright} 2024 Oxford University Press. All rights reserved.",
year = "2024",
doi = "10.1093/ejendo/lvae047",
language = "English",
volume = "190",
pages = "382--390",
journal = "European Journal of Endocrinology",
issn = "0804-4643",
publisher = "BioScientifica Ltd.",
number = "5",

}

RIS

TY - JOUR

T1 - Long-term pituitary function and functional and patient-reported outcomes in severe acquired brain injury

AU - Marina, Djordje

AU - Feldt-Rasmussen, Ulla

AU - Klose, Marianne

N1 - Publisher Copyright: © 2024 Oxford University Press. All rights reserved.

PY - 2024

Y1 - 2024

N2 - Objective: Assessment of posttraumatic hypothalamic–pituitary dysfunctions is expected to be the most relevant assessment to offer patients with severe intracranial affection. In this study, we aim to investigate the prevalence of hypopituitarism in patients with severe acquired traumatic brain injury (TBI) compared with nontraumatic brain injury (NTBI) and to relate pituitary insufficiency to functional and patient-reported outcomes. Design: This is a prospective study. Methods: We included patients admitted for inpatient neurorehabilitation after severe TBI (N = 42) and NTBI (N = 18). The patients underwent a pituitary function assessment at a mean of 2.4 years after the injury. Functional outcome was assessed by using Functional Independence Measure and Glasgow Outcome Scale-Extended (both 1 year after discharge from neurorehabilitation) and patient-reported outcome was assessed by using Multiple Fatigue Inventory-20 and EQ-5D-3L. Results: Hypopituitarism was reported in 10/42 (24%) patients with TBI and 7/18 (39%) patients with NTBI (P = .23). Insufficiencies affected 1 axis in 14/17 (82%) patients (13 hypogonadotropic hypogonadism and 1 growth hormone [GH] deficiency) and 2 axes in 3/17 (18%) patients (1 hypogonadotropic hypogonadism and GH deficiency, and 2 hypogonadotropic hypogonadism and arginin vasopressin deficiency). None had central hypoadrenalism or central hypothyroidism. In patients with both TBI and NTBI, pituitary status was unrelated to functioning and ability scores at 1 year and to patient-reported outcome scores at a mean of 2.4 years after the injury. Conclusion: Patients with severe acquired brain injury may develop long-term hypothalamus–pituitary insufficiency, with an equal occurrence in patients with TBI and NTBI. In both types of patients, mainly isolated deficiencies, most commonly affecting the gonadal axis, were seen. Insufficiencies were unrelated to functional outcomes and patient-reported outcomes, probably reflecting the complexity and heterogeneous manifestations in both patient groups.

AB - Objective: Assessment of posttraumatic hypothalamic–pituitary dysfunctions is expected to be the most relevant assessment to offer patients with severe intracranial affection. In this study, we aim to investigate the prevalence of hypopituitarism in patients with severe acquired traumatic brain injury (TBI) compared with nontraumatic brain injury (NTBI) and to relate pituitary insufficiency to functional and patient-reported outcomes. Design: This is a prospective study. Methods: We included patients admitted for inpatient neurorehabilitation after severe TBI (N = 42) and NTBI (N = 18). The patients underwent a pituitary function assessment at a mean of 2.4 years after the injury. Functional outcome was assessed by using Functional Independence Measure and Glasgow Outcome Scale-Extended (both 1 year after discharge from neurorehabilitation) and patient-reported outcome was assessed by using Multiple Fatigue Inventory-20 and EQ-5D-3L. Results: Hypopituitarism was reported in 10/42 (24%) patients with TBI and 7/18 (39%) patients with NTBI (P = .23). Insufficiencies affected 1 axis in 14/17 (82%) patients (13 hypogonadotropic hypogonadism and 1 growth hormone [GH] deficiency) and 2 axes in 3/17 (18%) patients (1 hypogonadotropic hypogonadism and GH deficiency, and 2 hypogonadotropic hypogonadism and arginin vasopressin deficiency). None had central hypoadrenalism or central hypothyroidism. In patients with both TBI and NTBI, pituitary status was unrelated to functioning and ability scores at 1 year and to patient-reported outcome scores at a mean of 2.4 years after the injury. Conclusion: Patients with severe acquired brain injury may develop long-term hypothalamus–pituitary insufficiency, with an equal occurrence in patients with TBI and NTBI. In both types of patients, mainly isolated deficiencies, most commonly affecting the gonadal axis, were seen. Insufficiencies were unrelated to functional outcomes and patient-reported outcomes, probably reflecting the complexity and heterogeneous manifestations in both patient groups.

KW - acquired brain injury

KW - functional outcome

KW - neurorehabilitation

KW - patient-reported outcome

KW - pituitary function

KW - traumatic brain injury

U2 - 10.1093/ejendo/lvae047

DO - 10.1093/ejendo/lvae047

M3 - Journal article

C2 - 38679947

AN - SCOPUS:85193309394

VL - 190

SP - 382

EP - 390

JO - European Journal of Endocrinology

JF - European Journal of Endocrinology

SN - 0804-4643

IS - 5

ER -

ID: 392985836